MARKET

FDMT

FDMT

4D Molecular Therapeutics Inc.
NASDAQ
11.62
+0.02
+0.17%
After Hours: 11.62 0 0.00% 16:07 06/24 EDT
OPEN
11.81
PREV CLOSE
11.60
HIGH
11.81
LOW
11.32
VOLUME
1.05M
TURNOVER
--
52 WEEK HIGH
12.34
52 WEEK LOW
3.680
MARKET CAP
607.45M
P/E (TTM)
-4.3079
1D
5D
1M
3M
1Y
5Y
1D
10 small-cap U.S. healthcare stocks with the strongest momentum grades
Seeking Alpha · 10h ago
4D Molecular Therapeutics CEO David Kirn disposes of 114,746 common shares worth $1.2 million
PUBT · 1d ago
4D Molecular Therapeutics Stockholders Back Directors and Governance
TipRanks · 2d ago
4D Molecular Therapeutics shareholders elect Class III directors at annual meeting
PUBT · 2d ago
Weekly Report: what happened at FDMT last week (0615-0619)?
Weekly Report · 2d ago
Weekly Report: what happened at FDMT last week (0608-0612)?
Weekly Report · 06/15 09:18
4D Molecular Therapeutics grants 66,900 RSUs to seven new employees under inducement plan
PUBT · 06/12 20:05
4DMT Announces New Employment Inducement Grants
Barchart · 06/12 15:05
More
About FDMT
4D Molecular Therapeutics, Inc. is a late-stage biotechnology company advancing durable and disease-targeted therapeutics. The Company's lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) with a single, safe, intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. Its lead indication for 4D-150 is wet age-related macular degeneration, which is in Phase III development, and second indication is diabetic macular edema. The Company is developing 4D-710 for the treatment of a range of people with cystic fibrosis independent of their specific CFTR mutation. 4D-710 is an investigational genetic medicine candidate using the A101 vector for the treatment of cystic fibrosis lung disease. The Company's non-core programs include 4D-175, 4D-725, and 4D-310.

Webull offers 4D Molecular Therapeutics Inc stock information, including NASDAQ: FDMT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FDMT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FDMT stock methods without spending real money on the virtual paper trading platform.